mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |